David Baram - co-founder and CEO of Emendo Biotherapeutics

Send us a text In this episode of Life Science Success, my guest is David Baram. David Baram is the co-founder and CEO of Emendo Biotherapeutics. David has taken Emendo from the pre-seed stage through multiple financing rounds and a successful acquisition in 2020. Don Davis, PhD, MBA interviews David Baram, PhD, CEO of Emendo Biotherapeautics Mendo is focused on developing gene editing therapies for rare and prevalent diseases, including cardiovascular diseases. They discuss the chall...